Aptamer Interfaces for Serum-Based Gastric Cancer Detection: From Molecular Recognition to Clinical Decision
Preprint
- 2 November 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Gastric cancer is the fifth most commonly diagnosed malignancy and the fifth leading cause of cancer death worldwide, and it remains lethal chiefly because it is detected late. Endoscopic screening demonstrably works where it is deployed at scale, but endoscopy cannot be extended to the several hundred million people who would need it; a blood test that stratifies risk before endoscopy is therefore the only realistic route to population-level early detection. Aptamers-short, chemically synthesizable nucleic acid ligands-are attractive recognition elements for such a test, and more than a decade of work has produced hundreds of aptasensors that detect gastric cancer serum markers with impressive analytical sensitivity. Almost none has reached clinical use. Here we argue that this impasse is not a problem of affinity, nor of limit of detection, but of interface design. We resolve aptamer-based serum diagnostics into four coupled interfaces-molecular recognition, the serum matrix, signal transduction and clinical evidence-and show that each has been optimized locally while the constraints they impose jointly have been ignored. We then specify a reference architecture and a minimum evidence standard for a gastric cancer serum aptamer test, and identify the five measurements that would move the field from demonstration to deployment.Keywords
All Related Versions
This publication has 122 references indexed in Scilit:
- Matrix‐Activated Aptamer Sensors for Human Serum AnalysisAngewandte Chemie International Edition, 2026
- Gastric CancerJAMA, 2026
- Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countriesCancer, 2025
- Evolution of Multivalent Aptamer Corona for High‐Throughput Multiplexed Detection of Multiple CancersAdvanced Science, 2025
- Microfluidic-SERS sensing system based on dual signal amplification and aptamer for gastric cancer detectionMicrochimica Acta, 2024
- An aptamer‐guided fluorescence polarisation platform for extracellular vesicle liquid biopsyJournal of Extracellular Vesicles, 2024
- Aptamer‐Based DNA Allosteric Switch for Regulation of Protein ActivityAdvanced Science, 2024
- Aptamer‐functionalized field‐effect transistor biosensors for disease diagnosis and environmental monitoringExploration, 2023
- De Novo Evolution of an Antibody‐Mimicking Multivalent Aptamer via a DNA FrameworkSmall Methods, 2023
- Allosteric Regulation of Aptamer Affinity through Mechano‐Chemical Coupling**Angewandte Chemie International Edition, 2023